Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 3/2011

01-03-2011 | Reproductive Medicine

Genetic aspects of premature ovarian failure: a literature review

Authors: Emerson Barchi Cordts, Denise Maria Christofolini, Aline Amaro dos Santos, Bianca Bianco, Caio Parente Barbosa

Published in: Archives of Gynecology and Obstetrics | Issue 3/2011

Login to get access

Abstract

Background

The diagnosis of premature ovarian failure (POF) is based on the finding of amenorrhea before the age of 40 years associated with follicle-stimulating hormone levels in the menopausal range. It is a heterogeneous disorder affecting approximately 1% of women <40 years, 1:10,000 women by age 20 years and 1:1,000 women by age 30 years. POF is generally characterized by low levels of gonadal hormones (estrogens and inhibins) and high levels of gonadotropins (LH and FSH) (hypergonadotropic amenorrhea).

Methods

Review of significant articles regarding genetic causes that are associated with POF.

Results

Heterogeneity of POF is reflected by a variety of possible causes, including autoimmunity, toxics, drugs, as well as genetic defects. Changes at a single autosomal locus and many X-linked loci have been implicated in women with POF. X chromosome abnormalities (e.g., Turner syndrome) represent the major cause of primary amenorrhea associated with ovarian dysgenesis. Many genes have been involved in POF development, among them BMP15, FMR1, FMR2, LHR, FSHR, INHA, FOXL2, FOXO3, ERα, SF1, ERβ and CYP19A1 genes.

Conclusion

Despite the description of several candidate genes, the cause of POF remains undetermined in the vast majority of cases.
Literature
1.
Santoro N (2003) Mechanisms of premature ovarian failure. Ann Endocrinol 64:87–92
2.
3.
Vilodre LC, Moretto M, Kohek MB, Spritzer PM (2007) Premature ovarian failure: present aspects. Arq Bras Endocrinol Metabol 51(6):920–929PubMed
4.
Welt CK (2008) Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) 68(4):499–509CrossRef
5.
Timmreck LS, Reindollar RH (2003) Contemporary issues in primary amenorrhea. Obstet Gynecol Clin North Am 30(2):287–302CrossRefPubMed
6.
Van Kasteren YM, Schoemaker J (1999) Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 5:483–492CrossRefPubMed
7.
8.
Fassnacht W, Mempel A, Strowitzki T, Vogt PH (2006) Premature ovarian failure (POF) syndrome: towards the molecular clinical analysis of its genetic complexity. Curr Med Chem 13(12):1397–1410CrossRefPubMed
9.
Bretherick KL, Hanna CW, Currie LM, Fluker MR, Hammond GL, Robinson WP (2008) Estrogen receptor alpha gene polymorphisms are associated with idiopathic premature ovarian failure. Fertil Steril 89(2):318–324CrossRefPubMed
10.
11.
Conway GS, Hettiarachchi S, Murray A, Jacobs PA (1995) Fragile X premutations in familial premature ovarian failure. Lancet 346(8970):309–310CrossRefPubMed
12.
13.
Bianco B, Oliveira KC, Guedes AD, Barbosa CP, Lipay MV, Verreschi IT (2010) OCT4 gonadal gene expression related to the presence of Y-chromosome sequences in Turner syndrome. Fertil Steril 94(6):2347–2349CrossRefPubMed
14.
Bianco B, Nunes Lipay MV, Guedes AD, Verreschi IT (2008) Clinical implications of the detection of Y-chromosome mosaicism in Turner’s syndrome: report of 3 cases. Fertil Steril 90(4):1197.e17–1197.e20
15.
16.
Ogata T, Matsuo N (1995) Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet 95:607–629CrossRefPubMed
17.
Tartaglia NR, Howell S, Sutherland A, Wilson R, Wilson L (2010) A review of trisomy X (47, XXX). Orphanet J Rare Dis 5:8CrossRefPubMed
18.
Linden MG, Bender BG, Harmon RJ, Mrazek DA, Robinson A (1988) 47, XXX: what is the prognosis? Pediatrics 82(4):619–630PubMed
19.
Lin HJ, Ndiforchu F, Patell S (1993) Exstrophy of the cloaca in a 47, XXX child: review of genitourinary malformations in triple-X patients. Am J Med Genet 45(6):761–763CrossRefPubMed
20.
Villanueva AL, Rebar RW (1983) Triple-X syndrome and premature ovarian failure. Obstet Gynecol 62(3 Suppl):70s–73sPubMed
21.
Goswami R, Goswami D, Kabra M, Gupta N, Dubey S, Dadhwal V (2003) Prevalence of the triple X syndrome in phenotypically normal women with premature ovarian failure and its association with autoimmune thyroid disorders. Fertil Steril 80(4):1052–1054CrossRefPubMed
22.
Persani L, Rossetti R, Cacciatore C, Bonomi M (2009) Primary ovarian insufficiency: X chromosome defects and autoimmunity. J Autoimmun 33(1):35–41CrossRefPubMed
23.
24.
Hogan BL (1996) Bmps: multifunctional regulators of mammalian embryonic development. Harvey Lect 92:83–98PubMed
25.
McNatty KP, Juengel JL, Reader KL, Lun S, Myllymaa S, Lawrence SB et al (2005) Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function in ruminants. Reproduction 129:481–487CrossRefPubMed
26.
Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juengel JL, Jokiranta TS et al (2000) Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 25:279–283CrossRefPubMed
27.
Di Pasquale E, Beck-Peccoz P, Persani L (2004) Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 75:106–111CrossRefPubMed
28.
Zinn AR, Tonk VS, Chen Z, Flejter WL, Gardner HA, Guerra R et al (1998) Evidence for a Turner syndrome locus or loci at Xp11.2–p22.1. Am J Hum Genet 63:1757–1766CrossRefPubMed
29.
McNatty KP, Smith P, Moore LG, Reader K, Lun S, Hanrahan JP et al. (2005) Oocyte-expressed genes affecting ovulation rate. Mol Cell Endocrinol 29:234(1–2):57–66
30.
Tiotiu D, Alvaro Mercadal B, Imbert R, Verbist J, Demeestere I, De Leener A et al (2010) Variants of the BMP15 gene in a cohort of patients with premature ovarian failure. Hum Reprod 25(6):1581–1587CrossRefPubMed
31.
Zhang P, Shi YH, Wang LC, Chen ZJ (2007) Sequence variants in exons of the BMP-15 gene in Chinese patients with premature ovarian failure. Acta Obstet Gynecol Scand 86(5):585–589CrossRefPubMed
32.
Ledig S, Röpke A, Haeusler G, Hinney B, Wieacker P (2008) BMP15 mutations in XX gonadal dysgenesis and premature ovarian failure. Am J Obstet Gynecol 98(1):84.e1–84.e5
33.
Amiri K, Hagerman RJ, Hagerman PJ (2008) Fragile X-associated tremor/ataxia syndrome: an aging face of the fragile X gene. Arch Neurol 65:19–25CrossRefPubMed
34.
35.
Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A et al (2006) Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129(Pt 1):243–255PubMed
36.
Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP et al (2007) Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod 22:2142–2152CrossRefPubMed
37.
Christofolini DM, Pinheiro FS, Bianco B, Melaragno MI, Ramos AP, Brunoni D et al (2009) Síndrome de tremos e ataxia associada ao X frágil: rastreamento por PCR em amostras de idosos. Arq Bras Ciências Saúde 34:1–5
38.
Hagerman RJ, Leavitt BR, Farzin F, Jacquemont S, Greco CM, Brunberg JA et al (2004) Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 74:1051–1056CrossRefPubMed
39.
Corrigan EC, Raygada MJ, Vanderhoof VH, Nelson LM (2005) A woman with spontaneous premature ovarian failure gives birth to a child with fragile X syndrome. Fertil Steril 84(5):1508CrossRefPubMed
40.
Lin YS, Yang ML (2006) Familial premature ovarian failure in female premutated carriers of fragile X syndrome: a case report and literature review. Taiwan J Obstet Gynecol 45(1):60–63CrossRefPubMed
41.
Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, He W et al (2005) Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 20:402–412CrossRefPubMed
42.
Murray A, Webb J, Dennis N, Conway G, Morton N (1999) Microdeletions in FMR2 may be a significant cause of premature ovarian failure. J Med Genet 36(10):767–770PubMed
43.
Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH (1995) Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA 92:1322–1326CrossRefPubMed
44.
Liao WX, Roy AC, Chan C, Arulkumaran S, Ratnam SS (1998) A new molecular variant of luteinizing hormone associated with female infertility. Fertil Steril 69(1):102–106CrossRefPubMed
45.
Piersma D, Verhoef-Post M, Berns EM, Themmen AP (2007) LH receptor gene mutations and polymorphisms: an overview. Mol Cell Endocrinol 282(6):260–262
46.
Sundblad V, Chiauzzi VA, Escobar ME, Dain L, Charreau EH (2004) Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF). Mol Cell Endocrinol 222(1–2):53–59CrossRefPubMed
47.
Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J et al. (1995) Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82:959–968
48.
Vilodre LC, Kohek MB, Spritzer PM (2008) Screening of follicle-stimulating hormone receptor gene in women with premature ovarian failure in southern Brazil and associations with phenotype. J Endocrinol Invest 31(6):552–557PubMed
49.
Ghadami M, El-Demerdash E, Salama SA, Binhazim AA, Archibong AE, Chen X et al (2010) Toward gene therapy of premature ovarian failure: intraovarian injection of adenovirus expressing human FSH receptor restores folliculogenesis in FSHR(−/−) FORKO mice. Mol Hum Reprod 16(4):241–250CrossRefPubMed
50.
51.
Groome NP, Illingworth PJ, O’Brien M, Cooke I, Ganesan TS, Baird DT et al (1994) Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf) 40(6):717–723CrossRef
52.
Groome NP, Illingworth PJ, O’Brien M, Pai R, Rodger FE, Mather JP et al (1996) Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81(4):1401–1405CrossRefPubMed
53.
Ying SY (1988) Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 9:267–293CrossRefPubMed
54.
Shelling AN, Burton KA, Chand AL, van Ee CC, France JT, Farquhar CM et al (2000) Inhibin: a candidate gene for premature ovarian failure. Hum Reprod 15(12):2644–2649CrossRefPubMed
55.
Marozzi A, Vegetti W, Manfredini E, Tibiletti MG, Testa G, Crosignani PG et al (2000) Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod 15(8):1874–1875CrossRef
56.
Harris SE, Chand AL, Winship IM, Gersak K, Nishi Y, Yanase T et al. (2005) INHA promoter polymorphisms are associated with premature ovarian failure. Mol Hum Reprod 11:779–84.40
57.
Dixit H, Rao KL, Padmalatha V, Kanakavalli M, Deenadayal M, Gupta N et al (2006) Expansion of the germline analysis for the INHA gene in Indian women with ovarian failure. Hum Reprod 21(6):1643–1644CrossRefPubMed
58.
Woad KJ, Watkins WJ, Prendergast D, Shelling AN (2006) The genetic basis of premature ovarian failure. Aust NZ J Obstet Gynaecol 46:242–244CrossRef
59.
Sundblad V, Chiauzzi VA, Andreone L, Campo S, Charreau EH, Dain L (2006) Controversial role of inhibin alpha-subunit gene in the aetiology of premature ovarian failure. Hum Repro 21(5):1154–1160CrossRef
60.
Santoro N, Adel T, Skurnick JH (1999) Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril 71:658–662CrossRefPubMed
61.
Pisarska MD, Bae J, Klein C, Hsueh AJ (2004) Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology 145:3424–3433CrossRefPubMed
62.
Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, Treier AC et al (2004) The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131:933–942CrossRefPubMed
63.
Uda M, Ottolenghi C, Crisponi L, Garcia JE, Deiana M, Kimber W et al (2004) Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet 13:1171–1181CrossRefPubMed
64.
Jeyasuria P, Ikeda Y, Jamin SP, Zhao L, De Rooij DG, Themmen AP et al (2004) Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol Endocrinol 18:1610–1619CrossRefPubMed
65.
Park M, Shin E, Won M, Kim JH, Go H, Kim HL et al (2010) FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells. Mol Endocrinol 24(5):1024–1036CrossRefPubMed
66.
Watkins WJ, Umbers AJ, Woad KJ, Harris SE, Winship IM, Gersak K et al (2006) Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure. Fertil Steril 86(5):1518–1521CrossRefPubMed
67.
Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA (2003) Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301(5630):215–218CrossRefPubMed
68.
Yoon SH, Choi YM, Hong MA, Lee GH, Kim JJ, Im HJ et al (2010) Estrogen receptor alpha gene polymorphisms in patients with idiopathic premature ovarian failure. Hum Reprod 25(1):283–287CrossRefPubMed
69.
Lindzey J, Jayes FL, Yates MM, Couse JF, Korach KS (2006) The bi-modal effects of estradiol on gonadotropin synthesis and secretion in female mice are dependent on estrogen receptor-alpha. J Endocrinol 191(1):309–317CrossRefPubMed
70.
Walter P, Green S, Greene G, Krust A, Bornert JM, Jeltsch JM et al (1985) Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci USA 82(23):7889–7893CrossRefPubMed
71.
Mosselman S, Polman J, Dijkema R (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392(1):49–53CrossRefPubMed
72.
Kolibianakis EM, Papanikolaou EG, Fatemi HM, Devroey P (2005) Estrogen and folliculogenesis: is one necessary for the other? Curr Opin Obstet Gynecol 17(3):249–253CrossRefPubMed
73.
Weel AE, Uitterlinden AG, Westendorp IC, Burger H, Schuit SC, Hofman A et al (1999) Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 84(9):3146–3150CrossRefPubMed
74.
Stavrou I, Zois C, Ioannidis JP, Tsatsoulis A (2002) Association of polymorphisms of the oestrogen receptor alpha gene with the age of menarche. Hum Reprod 17(4):1101–1105CrossRefPubMed
75.
Syrrou M, Georgiou I, Patsalis PC, Bouba I, Adonakis G, Pagoulatos GN (1999) Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction. Am J Med Genet 84(3):306–308CrossRefPubMed
76.
Kim S, Pyun JA, Kang H, Kim J, Cha DH, Kwack K (2010) Epistasis between CYP19A1 and ESR1 polymorphisms is associated with premature ovarian failure. Fertil Steril [Epub ahead of print]
77.
78.
Bidet M, Bachelot A, Touraine P (2008) Premature ovarian failure: predictability of intermittent ovarian function and response to ovulation induction agents. Current Opin Obstet Gynaecol 20:416–420CrossRef
79.
Picton HM, Harris SE, Muruvoi W, Chambers EL (2008) The in vitro growth and maturation of follicles. Reproduction 136:703–715CrossRefPubMed
80.
van Kasteren Y, Schoemaker J (1999) Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 5:483–492CrossRefPubMed
Metadata
Title
Genetic aspects of premature ovarian failure: a literature review
Authors
Emerson Barchi Cordts
Denise Maria Christofolini
Aline Amaro dos Santos
Bianca Bianco
Caio Parente Barbosa
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 3/2011
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1815-4

Other articles of this Issue 3/2011

Archives of Gynecology and Obstetrics 3/2011 Go to the issue

Short Communication

A case of postpartum cerebral angiitis and review of the literature

Short Communication

Dysuria: don’t take it lightly

Gynecologic Oncology

Use of a genomic test (MammaPrint™) in daily clinical practice to assist in risk stratification of young breast cancer patients

Gynecologic Oncology

Pretreatment study of P53 overexpression for selection of candidates for pelvic lymphadenectomy in clinical stage I endometrial carcinoma: a randomized-controlled study

Materno-fetal Medicine

Normal range for fetal urine production rate by 3-D ultrasound in Brazilian population

Materno-fetal Medicine

Use of complementary and alternative medicine during pregnancy and delivery